Erythropoietic agents in routine clinical practice: a retrospective observational survey of epoetin alfa, epoetin beta and darbepoetin alfa use in anaemia patients with cancer

被引：0
|
作者：
Pujade-Lauraine, Eric [1 ]
Richard, Alain J. [2 ]
Sapede, Claudine [3 ]
机构：
[1] CHU, Hotel Dieu, Serv Oncol, Paris, France
[2] GECEM SA, Paris, France
[3] F Hoffmann La Roche & Cie AG, PBSE, Basel, Switzerland
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [21] Epoetin alfa and darbepoetin alfa anemia treatment outcomes in cancer patients from a VA perspective
    Papatheofanis, FJ
    Fastenau, JM
    Chiang, T
    Piech, CT
    VALUE IN HEALTH, 2004, 7 (03) : 246 - 246
  • [22] 2007 Standards, Options, and Recommendations: Use of Erythropoiesis-Stimulating Agents (ESA: Epoetin Alfa, Epoetin Beta, and Darbepoetin) for the Management of Anemia in Children With Cancer
    Marec-Berard, Perrine
    Chastagner, Pascal
    Kassab-Chahmi, Diana
    Casadevall, Nicole
    Marchal, Christian
    Misset, Jean-Louis
    Ray-Coquard, Isabelle
    PEDIATRIC BLOOD & CANCER, 2009, 53 (01) : 7 - 12
  • [23] Utilization trends of epoetin alfa and darbepoetin alfa in adult patients with cancer receiving chemotherapy in community practice settings.
    Coletti, T
    Howell, JB
    Todoroff, K
    Gregory, KL
    Fastenau, JM
    BLOOD, 2004, 104 (11) : 413B - 413B
  • [24] Dose efficiency of aranesp (darbepoetin alfa) compared with epoetin alfa/beta in dialysis patients - A meta analysis
    Torres, Pablo Urena
    Maetzel, Andreas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 193 - 194
  • [25] Differences in treatment practice, response rates and cost of Epoetin alfa and Darbepoetin alfa treatment for anemic cancer patients: A retrospective analysis from Sweden
    Persson, U
    Borg, S
    Jansson, S
    Ekman, T
    Franksson, L
    Friesland, S
    Larsson, AM
    VALUE IN HEALTH, 2004, 7 (06) : 681 - 681
  • [26] Effects of darbepoetin alfa and epoetin beta pegol on iron kinetics in hemodialysis patients
    Sawa J.
    Inaba M.
    Noguchi K.
    Nakagawa C.
    Kuwamura M.
    Kuwamura Y.
    Wada N.
    Kitatani K.
    Kawaguchi Y.
    Kumeda Y.
    Renal Replacement Therapy, 2 (1)
  • [27] Conversion from Epoetin Alfa to Darbepoetin Alfa for Management of Anaemia in a Community Chronic Kidney Disease Centre A Retrospective Cohort Study
    Gobin, Jaya
    Cernii, Aura
    McLean, Rosella
    Finkelstein, Fredric O.
    Simon, David B.
    CLINICAL DRUG INVESTIGATION, 2011, 31 (02) : 113 - 120
  • [28] Conversion from Epoetin Alfa to Darbepoetin Alfa for Management of Anaemia in a Community Chronic Kidney Disease CentreA Retrospective Cohort Study
    Jaya Gobin
    Aura Cernii
    Rosella McLean
    Fredric O. Finkelstein
    David B. Simon
    Clinical Drug Investigation, 2011, 31 : 113 - 120
  • [29] Regarding "randomized comparison of epoetin alfa and darbepoetin alfa in anemic patients with cancer receiving chemotherapy" - In Reply
    Waltzman, Roger
    ONCOLOGIST, 2006, 11 (05): : 536 - 537
  • [30] Comment: Epoetin alfa versus darbepoetin alfa for cancer patients with treatment-related anemia - Reply
    Cersosimo, RJ
    Jacobson, DR
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (05) : 999 - 999
12345